跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GAVISCON LIQUID - HSA Drug Approval Details
Approvals
/
HSA
/
GAVISCON LIQUID
Approved
THERAPEUTIC
GAVISCON LIQUID
RECKITT BENCKISER HEALTHCARE (UK) LTD (UNITED KINGDOM)
🇸🇬 Health Sciences Authority
Approval Date
Sep 13, 1997
Approval ID
0bf9db7835983313
Company
RECKITT BENCKISER HEALTHCARE (UK) LTD (UNITED KINGDOM)
Type
Therapeutic
Approval Details
Approval Id
0bf9db7835983313
Drug Name
GAVISCON LIQUID
Product Name
GAVISCON LIQUID
Approval Number
SIN09494P
Approval Date
1997-09-13
Registrant
RECKITT BENCKISER (SINGAPORE) PTE LTD
Licence Holder
RECKITT BENCKISER (SINGAPORE) PTE LTD
Drug Type
Therapeutic
Forensic Classification
GENERAL SALE LIST
Dosage Form
SUSPENSION
Route Of Administration
ORAL
Atc Code
A02BX13
Atc Item Name
alginic acid
Pharma Manufacturer Name
RECKITT BENCKISER (SINGAPORE) PTE LTD
Active Ingredients
CALCIUM CARBONATE
160 mg/10 ml
SODIUM BICARBONATE
267 mg/10 ml
SODIUM ALGINATE
500 mg/10 ml
CALCIUM CARBONATE
160 mg/10 ml
SODIUM ALGINATE
500 mg/10 ml
SODIUM BICARBONATE
267 mg/10 ml
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Sep 13, 1997
Approval ID
0bf9db7835983313
Type
Therapeutic
Back to HSA Approvals